A randomised, double-blind, placebo-controlled trial of tropisetron in patients with schizophrenia

BACKGROUND: Cognitive deficits in schizophrenia are associated with psychosocial deficits that are primarily responsible for the poor long-term outcome of this disease. Auditory sensory gating P50 deficits are correlated with neuropsychological deficits in attention, one of the principal cognitive d...

Descripción completa

Detalles Bibliográficos
Autores principales: Shiina, Akihiro, Shirayama, Yukihiko, Niitsu, Tomihisa, Hashimoto, Tasuku, Yoshida, Taisuke, Hasegawa, Tadashi, Haraguchi, Tadashi, Kanahara, Nobuhisa, Shiraishi, Tetsuya, Fujisaki, Mihisa, Fukami, Goro, Nakazato, Michiko, Iyo, Masaomi, Hashimoto, Kenji
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Primary research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2901366/
https://www.ncbi.nlm.nih.gov/pubmed/20573264
http://dx.doi.org/10.1186/1744-859X-9-27

Ejemplares similares

Ejemplares similares